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ABSTRACT 
 
EXPLOITING FRAGMENT-ION COMPLEMENTARITY FOR 
PEPTIDE DE NOVO SEQUENCING FROM COLLISION INDUCED 
DISSOCIATION TANDEM MASS SPECTRA 
  
Peptide identification from mass spectrometric data is a key step in proteomics 
because this field provides sequence, quantitative, and modification data of actually 
expressed proteins. Two approaches are generally deployed to interpret experimental 
MS/MS data, database searching and de novo sequencing. Database search method has 
been used successfully in proteomics projects for organisms with well-studied genomes. 
However, it is not applicable in situations where a target sequence is not in the protein 
database. This can happen for a number of reasons, including novel proteins, protein 
mutations and post-translational modifications. Because of the disadvantages of 
database searching method, a lot of research has focused on de novo sequencing method 
which assigns amino acid sequences to MS/MS spectra without the need for a database. 
 The aim of this study is to enhance the accuracy of de novo sequencing tools. 
One step commonly employed in all de novo sequencing tools is naming of fragment 
ions. It is essential to know which peak represents which ion type in order to traverse a 
spectrum graph to find an amino acid sequence that best explains the MS/MS spectrum. 
Different approaches have been tried to name ions and some success has been achieved 
in naming b-type ions and y-type ions.  
We have presented a new approach which enables the naming of not only b- and 
y-type ions but other arbitrary ion types as well. This enabled the detection of b-ion 
ladder. In the latter case, missing fragments were determined by using other named ion 
types. Furthermore, unexplained data in tandem mass spectra were reduced as much as 
possible. Therefore, a complete sequence will be derived by the new approach. 
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ÖZET 
 
PEPTT DE NOVO DZLM ÇN ÇARPIMALI-
NDÜKLENM TANDEM KÜTLE 
SPEKTRUMLARINDAK PARÇALANMI YONLARIN 
TAMAMLAYICILIINDAN YARARLANILMASI  
 
Kütle spekrumu verilerinden peptit tanımlaması proteomik çalımalarında temel 
bir adımdır. Çünkü bu alan, ifade olmu proteinin dizi, niceliksel ve modifikasyon 
çalımalarında kullanıldıından biyolojik sistemlerin anlaılmasına katkı salar. ki 
yaklaım deneysel tandem kütle spektrum verilerine uygulanır, bunlar veritabanı 
araması ve de novo dizilemedir. Veritabanı arama metodu, genomu tümüyle çalıılmı 
organizmaların proteomik projelerinde etkili bir ekilde kullanılmaktadır. Fakat, aranan 
peptit dizisi protein veritabanında bulunmuyor ise bu yaklaım uygulanamaz. 
Veritabanında bulunmama bazı nedenlerden dolayı olabilir. Örnein, çalıılan protein 
yeni ise, mutasyon ve tranlasyon sonrası modifikasyon içeriyorsa protein veritabanında 
bulunmaz. Bu dezavantaj nedeniyle, birçok aratırma de novo dizilimi metoduna 
odaklanmıtır. Çünkü, de novo dizilimi metodu tandem kütle spektrumlarınn peptide 
dizisini hiçbir veritabanına vereksinim duymadan belirleyebilir. 
Bu çalımanın amacı, de novo dizileme algoritmalarının doruluunun 
gelitirilmesidir. Fragment iyonlarını isimlendirme tüm de novo dizileme 
algoritmalarnın (genellikle ima edilir) ortak bir adımıdır. Çünkü, spektrum grafik 
kullanarak tandem kütle spektrumunu en iyi ifade eden amino asit dizisini bulmak için, 
fragment iyonlarının hangi iyon tipini gösterdiinin bilinmesi gerekmektedir. Farklı 
yaklaımlar iyon isimlendirme için denenmitir ve bazıları b-tipi iyonları ve y-tipi 
iyonlarını isimlendirerek baarılı olmutur. 
Yeni bir yaklaımla, sadece b-iyon tipi yada y-iyon tipi isimlendirerek deil, 
dier rastgele seçilmi iyon tiplerini de isimlendirerek sonuçta b-iyon tipi merdivenini 
saptamayı hedefledik. Ayrıca, eksik ve peptit dizilemede önemli olan iyonları da dier 
isimlendirilmi iyon tipleriyle bazı spektrumlarda saptadık. Bunlara ek olarak, tandem 
kütle spektralarındaki anlaılmayan veriler mümkün olduunca azaltılmıtır. Böylece, 
b-iyon tipi merdivenini kullanarak tam peptit dizisini bulmak mümkün olabilecekiır. 
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CHAPTER 1 

INTRODUCTION 
 
1.1. Proteins, Proteome, and Proteomics 
 
In the 19th century, proteins were discovered and named by Jöns Jakob 
Berzelius. Proteins are constructed from a set of 20 amino acids which are linked to each 
other by peptide bond. For all living organisms proteins have a crucial role.  They can 
act as enzymes which accelerate many important chemical reactions. Proteins also form 
the backbone of the cells and different cellular structures and participate in vital roles 
such as mitosis, cell motility and signaling. Their involvement in most of the cellular 
processes and functions highlights the significance of the proteins (Filén, 2008).
The protein synthesis in the cells is expressed according to the genetic code. 
Except in some viruses as RNA, genetic information is stored in DNA. A gene which 
represents a DNA sequence codes the corresponding protein. In protein synthesis, at 
first the DNA is transcribed to a mRNA transcript which is, then, further translated into 
a protein.  
In molecular biology, the central dogma refers to the relationship between DNA, 
mRNA and protein (Varki et al., 1999). The central dogma has been expanded due to 
existing of post-translational modification and alternative splicing. Post-translational 
modification (PTM) is the chemical modification of a protein after its translation. For 
various proteins, PTM is one of the later step in protein biosynthesis (Santos-Rosa et al., 
2002). Alternative splicing is a process by which the exons of the RNA produced by 
transcription of a gene are reconnected in multiple ways during RNA splicing (Leipzig, 
Pevzner, & Hever, 2004). The resulting different mRNAs may be translated into 
different protein isoforms. Therefore a single gene may code for multiple proteins 
(Pandey & Mann, 2000). The relationship between DNA, mRNA, alternative splicing, 
protein, posttranslational modification is referred as an expended central dogma of 
biology, see Figure 1.1. 
 
 
 2 
 
                     
Figure 1.1. Schematic illustration of expended central dogma.  
 (Source: Jakubowski, 2011) 
 
 
 
The term proteome was first introduced by Marc Wilkins in 1994. Wilkins 
abbreviated proteome from “PROTEin complement of the genOME” meaning the 
complete set of the proteins expressed by the cell (Wilkins et al., 1996). Then, the term 
proteomics was described as simply as “the large-scale analysis of proteins” (Pandey & 
Mann, 2000). Since mRNA transcripts can alternatively be spliced and translated 
proteins can be chemically modified in the cell, genomic studies alone cannot answer 
many questions which can be solved by proteomic approaches (Dunham et al., 1999), 
(Krogh, 1998). 
Proteomics is the study of proteins on a large scale to obtain an integrated view 
of the cellular processes, networks at the protein level. Proteomic approaches contain 
sequence analysis, structure determination and functional exploration of proteins, as 
well as the study of protein-protein interaction. In order to explore a novel protein, 
sequence analysis is the first and indispensable step that provides information for 
structural and functional proteomics studies (Washburn, Wolters, & Yates, 2001). 
Edman degradation method is used for sequence analysis (Edman & Begg, 1967). In the 
identification of large amounts of proteins for sequence, this method is limited in that it 
takes a long time for chemical reaction to occur. In that sense, the method is not 
efficient enough. Nowadays, mass spectrometry replaces the classic Edman degradation 
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method in protein and peptide sequencing due to its high accuracy, sensitivity and high 
throughput (Chait, 2006). 
 
1.1.1. Mass Spectrometry (MS) 
 
Mass spectrometry is an analytical technique to measure the mass-to-charge 
ratios (m/z) of ions. Although mass spectrometry has been used in analytical chemistry 
for over a century, only in the last two decades has the technology developed to offer 
adequately high resolution to make mass spectrometry an important tool for proteomics 
studies (Aebersold & Mann, 2003). A mass spectrometer has three main parts: an ion 
source that ionizes the molecules in the sample, a mass analyzer that separates the ions 
according to their mass-to-charge ratio, and a detector system that measures the 
abundance of ions with different mass-to-charge ratios. The main components of MS 
are illustrated in Figure 1.2.  
 
 
 
 
                                       
         
Figure 1.2. Main components of Mass Spectrometry. The figure adapted from Nathan Edward’s slide. 
(Source: Edwards, 2005) 
 
 
Mainly, mass spectrometry is used in protein identification. As shown in Figure 
1.3, when only the first stage MS is used, the peptide fragments are gained. This is 
called peptide mass fingerprinting which can be used to identify the protein (Henzel et 
al., 1999). To identify a protein, at first, the protein or protein mixture of interest is 
 4 
digested by a protease. Then, the resulting peptide fragments are ionized and measured 
to generate a mass spectrum with high specificity. This machine-generated mass 
spectrum is named experimental spectrum. For each protein in a database, a theoretical 
mass spectrum can be constructed by using a virtual digestion of a protein. Protein 
identification is achieved by matching the monitored peptide masses in the experimental 
mass spectrum with the theoretical masses in the virtual mass spectrum gained from a 
sequence database (Hernandez, Müller, & Appel, 2006).  
 
 
                                                            
      
 
Figure 1.3. Protein identification by peptide mass fingerprint. The figure was adapted from Nathan  
Edwards’s slide (Source: Edwards, 2005). 
 
 
However, this method suffers from the deficiencies that limit its utility in large 
proteomic studies. If the analyzed sample is very complex or the sequence database is 
very large, the protein assignments are likely to have low statistical significance. 
Tandem mass spectrometry becomes useful for high-throughput proteomic studies 
because it has a second stage of MS which gives more information about the peptide 
sequence (Bandeira, 2007).   
                                                                                                                                                 
 

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1.1.1.1. Tandem Mass Spectrometry (MS/MS) 
 
MS/MS is the most dominantly used tool in peptide identification and 
sequencing. Peptides are determined in complex mixtures by tandem mass 
spectrometry. Tandem mass spectrometry uses two mass analyzers in series to gain 
more detailed information about the protein of interest. A chamber where peptides are 
fragmented into small charged ions by Collision Induced Dissociation (CID) which is 
one of the several types of fragmentation methods connects the two mass analyzers. In 
Figure 1.4; MS1, MS2 and fragmentation region (chamber) are illustrated. The first 
stage MS (MS1) functions as a normal mass analyzer, where peptide fragments of a 
protein or protein mixture are measured according to their mass-to-charge ratios. 
Although all peptides go through the connection chamber, only peptides which are 
within a small range of m/z ratios are selected for CID. With inert gas atoms in the 
chamber the ions are collided and then the emerging ion fragments get in the second 
mass analyzer (MS2). Subsequently their m/z ratios are measured to generate a tandem 
mass spectrum (Kinter & Sherman, 2000).  
 
 
Figure 1.4. Components of Tandem Mass  Spectrometry (MS/MS). 
(Source: Zaidi, 2006) 
 
 
Tandem mass spectrometry is mainly used in peptide identification. In order to 
identify a peptide, proteins can be digested theoretically and the virtual spectra can be 
compared to the experimental spectrum. This method is called database search. Also, 
the sequence information of the peptide can be identified by using the experimental 
spectrum directly without need for the protein database. This method is called de novo 
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peptide sequencing. Detailed information about database search and de novo sequencing 
will be given in sections 1.1.2.1 and 1.1.2.2 After peptide identification is performed, 
proteins can be identified (Figure 1.5). In order to find a peptide sequence from a 
tandem mass spectrum, understanding the peptide fragmentation processes is an 
important point.  
 
 
                                     
 
Figure 1.5. Protein identification by tandem mass spectrum. The figure was adapted from Nathan 
Edwards’s slide (Source: Edwards, 2005). 
 
1.1.1.2. Peptide Fragmentation 
 
The most common method of fragmentation is CID (Wells & McLuckey, 2005). 
In the CID fragmentation process, for instance a peptide bond at a peptide molecule can 
break. The peptide is fragmented into two ions which are either from the N-terminus or 
from the C-terminus. In addition to b- and y-ions, in MS/MS spectra various types of 
ions can appear due to a variety of reasons. The first reason is “neutral loss ions”. The 
b- and y-ions may lose certain chemical groups such as H2O and NH3 and as a result 
neutral loss ions are formed (Papayannopoulos, 1995). The second reason is the 
“internal fragments”. The fragmentation can also occur at other positions in the 
backbone. If it occurs between the two carbons, the resulted ions are called a-ion and x- 
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ion.  If it occurs between a nitrogen and a carbon, the resulted ions are called c-ion and 
z-ion. As a result, the internal fragments are formed when more than one bond of peptide 
is broken. The third reason is “doubly or multiple charged b- and y-ions”. When more 
than one proton exists on the fragments, multiple charged b-ions and y-ions occur. The 
last reason is “unexplained data” of the spectrum. The pattern of occurrence of various 
ions is called fragmentation pattern of a peptide. The ions represent a characteristic 
pattern in tandem mass spectrometry which allows identification of selected peptides. 
However, actual tandem mass spectra are much more complicated due to occurrence of 
unknown ion types, unknown charges, missing ions, unexplained data, isotopic ions, 
and machine errors. Therefore, the identification of peptide sequences using tandem 
mass spectra remains a challenging task (Huang et al., 2005). 
 
 
H2N—CH—C—NH—CH—C—NH—CH—C—NH—CH—C—OH 
R1 R3 R2 R4 
O O O O 
a1 
xn 
b1 
yn 
c1 
zn 
scl
 
ifi 
a2 
xn-1 
                              
 
Figure 1.6. Fragmentation patterns of a peptide containing n residues  
( Source: Allmer, 2006). 
 
 
Possible ions resulting from peptide fragmentation are illustrated in Figure 1.6 
When the peptide bond, which is between two amino acids, is broken, b1 and yn ions are 
generated. These ions are complementary ion pairs because the combination of them 
gives the complete peptide sequence. From a peptide with n amino acids, n-1 b-ions and 
n-1 y-ions are generated by an ideal fragmentation. A complete b-ions and y-ions 
ladder, where two adjacent m/z values differ by fragment mass of only one amino acid, 
are formed by these b- and y-ions form. Table 1.1 illustrates an example of the b and y 
ion ladders. If the tandem mass spectrum does not include any unexplained data and 
contains only b-ion and y- ion types, it is much easier to find a complete b-ion or y-ion 
ladder. 
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          Table 1.1.  Ionization and fragmentation of peptide NH3 R1 - R2 - R3 - R4 COOH.  
                            R ( radical) group differs for each amino acid. 
 
Ions             b-ion sequences                      Ions                    y-ion sequences 
b1                (R1) +                                       y3                      (R2 - R3- R4) + 
b2                (R1 - R2) +                               y2                      (R3 - R4) + 
b3                (R1 - R2 - R3) +                       y1                      (R4) +
 
                                           
                                                                                           
1.1.2. MS/MS-Based Peptide Identification 
 
In order to find a peptide sequence from a MS/MS spectrum, generally two 
approaches are used: database searching and de novo sequencing. The database search 
method compares experimental MS/MS spectra with theoretically generated MS/MS 
spectra of each peptide derived from a protein sequence database, assuming that the 
query peptides exist in the protein sequence database. On the other hand, de novo 
sequencing method assigns amino acid sequences to MS/MS spectra without a need for 
a protein database (Forner, Foster, & Toppo, 2007).  
 
1.1.2.1. Database Search 
 
In database search methods, at first the proteins in the database are virtually 
digested by the protease. According to the molecular weight of the resulting peptides, 
they are then indexed. Only those with an approximate molecular weight matching to 
the precursor mass of the tandem mass spectrum are considered as candidates. Then, the 
theoretical spectra of those candidates are generated. In order to calculate the scores for 
the match of the theoretical spectrum and experimental spectrum, a scoring function is 
applied. The candidate which has the highest match score is close to be the peptide 
which generated the experimental spectrum. The database search method is illustrated 
in Figure 1.7 Since it depends on the protein database, the size of the database 
influences the searching speed and the prediction of the results. For instance, although a 
larger database provides more results, it requires longer searching time and leads to 
large false positive rates. On the contrary, smaller database can search faster but can 
also result in false peptide prediction.  
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Figure 1.7. Database Search  Method. Precursor mass of MS/MS spectrum can match so many peptide 
sequences from database. After generating theoretical MS/MS spectra from those candidates, 
match score is calculated for each candidate. The candidate which has highest match score can 
be the peptide sequence of experimental MS/MS spectrum. 
 
 
 
The most popular database search programs include SEQUEST (Eng, 
McCormack, & Yates, 1994), Mascot (Perkins, Pappin, Creasy, & Cottrell, 1999) and 
OMSSA (Godoy, Olsen, Souza, Li, Mortensen, & Mann, 2006). The database search 
algorithm is effective and has been used successfully in proteomics projects for 
organisms with well-studied genomes. However, it is not applicable in situations where 
a target sequence does not exist in the protein database. If proteins under study are 
novel, carry unknown mutations or post-translational modifications, a target sequence 
does not exist in the database. Because of the disadvantage of the database searching 
method, a variety research has focused on de novo sequencing methods. 
 
1.1.2.2. De Novo Sequencing 

The aim of de novo sequencing algorithms is to reconstruct the peptide sequence 
directly from a tandem mass spectrum without the aid of databases. Therefore, in 
principle, the de novo sequencing method can cope with limitations of the database 
search algorithms. Various de novo sequencing algorithms have been developed since 
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the late 1990’s, including Sherenga (Dancik, Addona, Clauser, Vath, & Pevzner, 1999), 
Lutefisk (Taylor & Johnson, 1997), the dynamic programming method (Chen, Kao, 
Tepel, Rush, & Church, 2001) and a suboptimal method (Lu & Chen, 2003), PEAKS 
(Ma, Doherty-Kirby, & Lajoie, 2003), DACSIM (Zhang Z., 2004), EigenMS (Bern & 
Goldberg, 2005), PepNovo (Frank & Pevzner, 2005) (Frank, Savitski, Nielsen, Zubarev, 
& Pevzner, 2007) and NovoHMM (Fischer et al., 2005). The basic problem of these 
algorithms is that they are inadequate to obtain a complete sequence or a full ladder of 
b- or y-ions. The mass difference between consecutive steps in a ladder or peaks is 
equal to an amino acid mass. Therefore, full ladder enable to find amino acid sequence 
of a peptide. This process is illustrated in Figure 1.8 However, in practice, due to 
incomplete fragmentations, isotopes, multiple fragmentations, unknown ion type and 
random unexplained data in tandem mass spectrum seriously restricts the efficacy of de 
novo algorithms stated above, and frequently causes false positive predictions. Hence, 
nowadays, de novo sequencing tools are not as extensively used as database search 
tools. 
 
 
 
 
Figure 1.8. De novo sequencing Method. Full b-ion and y-ion ladders are shown. Mass difference 
between b-ion or y-ion ladder gives the peptide sequence of a tandem mass spectrum  (Source: 
Chen, Kao, Tepel, Rush, & Church, 2001). 
 
 
In order to develop a reliable de novo sequencing algorithm, there are two main 
steps. The first one is generating a pool of candidates (Eng, McCormack, & Yates, 
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1994). To generate a pool of candidates, most of the de novo sequencing algorithms 
create a spectrum graph. The second one is designing a good scoring function to choose 
the best candidate from the pool (Havilio & Smilansky, 2003). In order to choose the 
best candidate, a dynamic programming algorithm is mostly used to find paths in the 
graph which represent peptide candidates.  
The dynamic programming algorithm works only if the scoring function is 
additive. Therefore, the selection of scoring functions is quite limited (The sum or the 
multiplication of the score of each ion equals the score of a peptide). Despite this 
limitation, various scoring functions have been proposed. The probability of different 
ion types in their scoring function is considered by Dancik (1999). Later, Frank and 
Pevzner (2005) developed a de novo sequencing algorithm which is called PepNovo by 
using a probability network with a hypothesis testing. At the same time, Bernd Fischer 
et al. (2005) proposed an HMM model called NovoHMM. In recent years, Frank and 
Pevzner (2005) presented a new version of PepNovo which suits to LTQ-FT data 
(Frank, Savitski, Nielsen, Zubarev, & Pevzner, 2007). The new version of PepNovo 
creates sequence tags up to 8 amino acids long which are then used to query the 
database for peptide identification and is therefore not a pure de novo sequencing 
algorithm. 
 
1.1.3. De Novo Sequencing Algorithms 
 
Over the years, in order to deal with the de novo sequencing problem, various 
algorithms have been developed. One of the early de novo sequencing algorithm uses 
the “naive method” which was developed by Sakurai, Matsuo, Matsuda and Katakuse 
(1984) and Hamm, Wison and Harvan (1986). This method lists all the possible 
candidate peptides according to the mass of the precursor ion of the tandem mass 
spectrum. Therefore, it is also called “exhaustive listing”. In order to find the best 
candidate peptide with the highest match, all the candidate peptides are compared with 
the experimental spectrum (tandem mass spectrum). However, there is a computational 
hardness because possible enormous list of candidates will exist for a usual precursor 
mass (Lu & Chen, 2004). 
The second method is called “subsequencing” which was developed by Johnson 
and Biemann (1989). In this approach, short sequences represent only a part of the 
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whole sequence. These short sequences (subsequences) account for some observed ions. 
The subsequences are extended to one residue until the whole sequence is tested. 
During this extension, if there is a significant matching with the experimental spectrum, 
those subsequences will be retained. However, the method is problematic in that some 
good candidate peptides might be discarded when some regions of a peptide are 
inadequately represented by fragmentation ions. It is important to highlight that the 
fragmentation frequencies are usually not evenly distributed over the whole peptide (Lu 
& Chen, 2004). 
The third method uses graphical display of the data which was developed by 
Scoble, Billet and Biemann (1987). In this approach, the same ion type series are 
allowed to find the peptide sequence because connections occur if the mass differences 
between the same type fragmentation ions equal to one of the amino acid mass. The 
approach is limited in high-throughput environments. However, it can be used for 
manual de novo interpretation of tandem mass spectra (Lu & Chen, 2004). 
The fourth method uses “graph theory” which was first proposed by Bartels 
(1990).  Later, the method was further developed by Hines, Falick, Burlingame and 
Gibson (1999), Fer nandez-de-Cossio, Gonzales and Besada (1995), Taylor and Johnson 
(1997) and Dancik, Addona, Clauser, Vath and Pevzner (1999). In this method, the 
experimental spectrum is transformed into a graph called “Spectrum Graph”. Each peak 
in the experimental  spectrum corresponds to a vertex  in the spectrum graph, and a 
directed edge is drawn between two vertices if the mass difference of the two vertices 
equals the mass of one amino acid  mass (Lu & Chen, 2004). In order to find paths, one 
of which can represent the peptide sequence of experimental spectrum, various 
algorithms have been designed, (Figure 1.9).  
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Figure 1.9. Spectrum Graph 
(Source: Allmer, 2011). 
 
 
Nowadays, for peptide identification, the most popular de novo sequencing 
algorithms are PEAKS, PepNovo, Lutefisk, Sherenga and some of which use the 
spectrum graph approach. In the next section, in addition to these, the Dynamic 
Programming and the Suboptimal Method are explained in more detail. 
 
1.1.3.1. PEAKS 

Ma, Doherty and Lajoie (2003) developed PEAKS. In this method, the raw 
MS/MS data is preprocessed by filtering unexplained data, centering peaks and 
deconvolving doubly and triply charged peaks into singly charged peaks. Based on how 
close a peak matches to a mass in the theoretical spectrum, reward or penalty is given. 
Ma et al (2003) have aimed to find sequence whose b- and y-ions maximizes the 
rewards at their mass value. Dynamic programming has been used to compute the 
10000 sequences with the highest scores. After that, the scores are refined by a more 
stringent scoring scheme which uses stricter mass error tolerance and then the best 
candidates are found using the new scoring scheme. In order to calibrate the minor 
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deviation in the MS/MS data, a recalibration method has been used. Finally, PEAKS 
calculates a confidence score for each top-scoring peptide sequence (Pevtsov, Fedulova, 
Mirzaei, Buck, & Zhang, 2006). 
 
1.1.3.2. PepNovo 
 
The PepNovo program which was developed by Frank and Pevzner (2005) is 
based on a probabilistic network modeling scoring method. A probabilistic network has 
been defined by three different types of dependencies: correlations between fragment 
ions, dependencies because of the relative position of the cleavage site in the peptide, 
and the influence of flanking amino acids to the cleavage site. Frank and Pevzner (2005) 
has integrated a hypothesis test idea into their scoring function and defined the score 
given to a mass m and spectrum S to be the logarithm of the likelihood ratio of the 
probabilities of the CID and random hypotheses. While the CID hypothesis assumes 
that mass m is caused by a genuine cleavage in the peptide, the random hypothesis 
assumes that mass m is caused by a random process.  
A spectral graph is built using only the top-ranking peaks in a tandem mass 
spectrum by a sliding window method. Also by using a combinatorial parent mass 
correction procedure, the parent mass is recalibrated. A dynamic programming which is 
similar to Chen et al’s algorithm is applied to find the highest asymmetric path in the 
spectrum graph. The uniqueness of Pepnovo comes from its scoring function (Bern, Cai, 
& Goldberg, 2007). 
 
1.1.3.3. Lutefisk 
 
The Lutefisk algorithm, which was developed by Taylor and Johnson (1997) 
identifies significant ions in the first step. In this step, local maxima and sliding 
windows methods are used. Then, the N- and the C- terminal evidence lists are detected. 
While the N-terminal ions are considered as b, b-NH3, b-H2O, a, a- NH3, a- H2O, the C-
terminal ions are considered as y, y- NH3 and y- H2O. Taylor and Johnson (2001) used 
an approximate probability the each ion, those of a, a- NH3, a- H2O, b- NH3, b- H2O, y- 
NH3 and y- H2O are half of that assigned to b and y. In the next step, the N-terminal and 
C-terminal evidence lists are combined into a spectrum graph in which the x-ordinate is 
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the nominal m/z values for b-ions and the y-ordinate is a sum of the various ion 
probabilities suggesting cleavage at each site. Once the spectrum graph is established, 
the program proceeds by tracing out sequences starting from the N-terminal. The 
process starts by finding b-ions which differ from N-terminal by one or two amino acids 
residue mass. After getting the completed sequences, b-ion values are scored according 
to an intensity-based score (Taylor & Johnson, 2001). 
 
1.1.3.4. Sherenga 
 
Developed by Dancik, Addona, Clauser, Vath and Pevzner (1999), Sherenga is 
the first algorithm importing the concept of spectrum graph and training data. In this 
algorithm, a set of training data is used to learn ion types of the peaks in the spectrum 
without any prior information from the fragmentation patterns. Then, in order to build a 
spectrum graph, the information of the ion types is used. Different ion types have been 
defined as a set, k is the number of ion types. Each peak in the spectrum creates k 
vertices. Two vertices u and v are connected by directed edge only if the mass 
difference between them equals to one amino acid. Dancik et al (1999) indicated that 
the peptide sequencing problem is transformed as the longest path problem in the 
directed acylic graph and that the longest path may not correspond to exact solutions 
because it may use multiple vertices associated with the same experimental peak. 
Finding the longest non-symmetric path is one solution to avoid multiple assignments of 
the same peaks. Dancik et al (1999) indicated that to find the longest non-symmetric 
path in the spectrum graph there is a need for the existence of an efficient algorithm. 
 
1.1.3.5. Dynamic Programming  
 
The first application of dynamic programming in de novo sequencing was 
proposed by Chen, Kao, Tepel, Rush and Church (2001). They first found forbidden 
pairs in the spectrum graph were non-interleaving. Then, in order to find the longest 
non-symmetric path in the spectrum graph, a dynamic programming method which 
makes the first polynomial time algorithm for de novo sequencing was designed. When 
Dancik’s idea (1999) is simplified, each peak is either b or y ions. Then, instead of the k 
vertices, each peak generates two vertices. If their mass difference equals to an amino 
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acid, two vertices are connected. Later a dynamic programming which is a common 
technique for solving optimization problems is used to get the optimal results. However, 
the optimal solution may not be the correct sequence which is produced by the 
experimental spectrum because unexplained data and unknown ions are interpretated as 
real ions.  For this reason, scientists are also interested in suboptimal solutions to reach 
the real sequence (Goto & Schwabe, 2008). 
 
1.1.3.6. Suboptimal Methods 
 
The suboptimal concept which was developed by Lu and Chen (2003) extended 
the previous dynamic programming method. In this method, the spectrum is 
transformed into a two dimensional matrix spectrum graph and then the suboptimal 
solutions are found. For each candidate peptide, a theoretical spectrum is generated and 
scored by using a simple scoring function. While S1 indicates the sum of the abundance 
levels of all of the ions in the theoretical spectrum, S2 represents the sum of the 
abundance levels of the ions that match with the experimental spectrum. In order to rank 
the results, the ratio of S2/S1 is used as the score. The ratio of S2/S1 shows how well 
each theoretical spectrum suits the experimental spectrum. Therefore, the candidate 
peptides are ranked according to the S2/S1 ratio.  
 
1.2. Aim of the Study 
 
The amino acid sequence of a protein has to be determined in order to solve its 
structure and function. Since the identification of the sequence of a peptide from the 
tandem mass spectrum is the first and common step to identify the protein, correct 
peptide identification is crucial for accurate protein sequence determination.  
Tandem mass spectrometry, which is a powerful tool for peptide sequencing, 
measures the mass to charge ratio of each peptide fragment. Since ion fragments 
information is very complex and can often lead to incorrect identification, diverse de 
novo sequencing and database search algorithms have been developed to gain correct 
peptide sequence. 
Although database searching is usually the first choice for peptide identification, 
de novo peptide sequencing plays an important role in dealing with the limitation of 
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database searching. Even though it is crucial to identify peptide sequences accurately in 
protein sequencing, unfortunately current de novo peptide sequencing algorithms cannot 
determine the peptide assignment with high correctness. Therefore, finding an accurate 
peptide sequence is still a challenging task. 
The aim of this study is to enhance the accuracy of the currently used de novo 
sequencing algorithms. In order to manage this goal, the present study focuses on the 
problems such as missing ions from tandem mass spectrum, unexplained data and unknown 
ion types. By using ion complementarity, the fragment ions are named. Therefore, named 
ions provide determination of missing ions which are crucial to obtain the b-ion ladder. 
Finding the b-ion ladder provides to get rid of unexplained data which causes complexity to 
tandem mass spectrum. Then, in order to determine the peptide sequence of tandem mass 
spectrum, the b-ion ladder is traversed using dynamic programming to derive the amino 
acid sequence.  
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CHAPTER 2 

                             MATERIALS AND METHODS 

2.1. Materials 

2.1.1. Tandem Mass Spectra Data Set 

In order to evaluate quality of the de novo sequencing algorithm, one public data 
set  which was developed and published by Keller et al (2002) and which was generated 
with a LCQ tandem mass spectrometer was used. One feature of the data set of low 
energy CID tandem mass spectra is that it was generated from a control mixture of 
known protein components. Keller and colleagues searched the human peptide database 
to find the correct peptide assignment with SEQUEST. Since they did not gain all of the 
peptide assignments accurate, alternative database search methods were used to find 
correct peptide identification in the rest of the spectra (Keller et al, 2002).  
The data set includes peptide assignments for Spectra of Singly Charged Ions, 
Spectra of Doubly Charged Ions and Spectra of Triply Charged Ions. They were used in 
the several studies to determine the quality of de novo sequencing algorithm. 
 
2.1.2. Computer 
 
 Another basic material used in the study is a computer which was used to keep 
the data set. In addition, NetBeans IDE platform was downloaded onto the computer, in 
order to generate the de novo sequencing algorithm by using Java programming 
language. After the algorithm was developed, it was tested on the data set to evaluate 
the algorithm. 
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2.1.3. Java 
 
 Java, which is a programming language, was developed by Oak. It was 
designed for handheld devices and set-top boxes. Since Oak was not successful, in 1995 
Sun altered the language to take the advantage of the burgeoning World Wide Web. 
Also, Oak’s name was changed to Java (Bilsel, 2009).  
Java has significant features such as Platform Independence, Object Orientation, 
Rich Standard Library, Applet Interface and Garbage Collection. Java compilers do not 
generate native code for a particular platform but rather ‘byte code’ instructions for the 
Java Virtual Machine (JVM). This feature of java is referred as Platform Independence. 
Making Java code operate on a specific platform is then simply a matter of writing a 
byte code interpreter to simulate a JVM (Figure 2.1). What this all means is that the 
same compiled byte code will run unmodified on any platform that supports Java 
(Daconta, 1996). Java is a pure object-oriented language. This property of java is called 
Object Orientation. It means that everything in a Java program is an object and 
everything is descended from a root object class. One of Java’s most attractive features 
is its standard library which is called Rich Standard Library. 
 
 
 
 
Figure 2.1. Java Execution Model. A Java Virtual Machine is a virtual machine capable of executing Java 
Byte     Code which is compiled from Java Source Code. 
 
 
 
The Java environment includes hundreds of classes and methods in six major 
functional areas (Chan & Lee, 1996). The first one is Language Support classes for 
advanced language features such as strings, arrays, threads, and exception handling. The 
second one is Utility classes like a random number generator, date and time functions, 
and container classes. The third one is Input/output classes to read and write data of 
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many types to and from a variety of sources.  The fourth one is Networking classes to 
allow inter-computer communications over a local network or the Internet. Abstract 
Window Toolkit for creating platform-independent GUI applications (Flanagan, 1996). 
In addition to being able to create stand-alone applications, Java developers can create 
applets that can be downloaded from a web page and run in a client browser (Gosling & 
Yellin, 1996). Also, Java does not require programmers to explicitly allocated memory. 
This feature is called Garbage Collection which makes Java programs easier to write 
and less prone to memory errors (Lemay & Perkins, 1996). Additionally, the popular 
C++ programming language is similar to the Java Syntax. Hence, this similarity is one 
of the factors enabling the rapid adoption of Java (Niemeyer & Peck, 1996).  
 
2.1.4. Netbeans 
 
NetBeans is both a framework for Java desktop applications and an integrated 
development environment (IDE). The Netbeans Platform provides a reusable 
framework in order to simplify the development of Java Swing (Swing is the primary 
Java GUI widget toolkit) desktop applications and offers reusable services such as user 
interface management (for instance menus and toolsbars), user setting management, 
storage management, window management, wizard framework, netbeans visual Library, 
integrated development tools.  
An IDE is computer software to help computer programmers develop software 
such as Java, JavaScript, PHP, Phthon, C, C++. The NetBeans IDE is written in Java. It 
can be run in Windows, Linux, Solaris and Mac OS, if the JVM is installed. For 
developing Java, a Java Development Kit (JDK) which is a Sun Microsystems product 
aimed at Java developers is necessary (Tulach, 2010). 
 
2.1.5. TortoiseSVN 

TortoiseSVN is a free open-source client for the Subversion version control 
system. Version control is a critical tool for programmers because it enables them to 
manage changes of files. The files are stored in a central repository. The repository can 
remember every change ever made to the files. Therefore, older versions of the files can 
be recovered. In addition, the client can reach all the information about the files such as 
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how and when the changes are done, and who changed them (Large, Küng, & Onken, 
2011). 
The features of TortoiseSVN are shell integration, icon overlays and easy access 
to Subversion commands. Shell integration means that TortoiseSVN integrates free of 
problems into the Windows shell (i.e. the explorer). Therefore, working with the tools 
which are familiar to the user can be kept. Icon overlays indicate that the status of every 
versioned file and folder. Hence, it is possible to see instantaneously what the status of 
working copy is. Easy access to Subversion commands means that all Subversion 
commands are available from the explorer context menu and Submenu of TortoiseSVN 
is added to there (Küng, Ongen, & Large, 2011). 
In the present study, in order to reach older versions of Java code which includes 
implementation of the algorithm, Subversion version control system was used in Origo. 
 
2.1.6. Origo 

Origo, which is a hosting platform, is available for both open-source and closed-
source projects. It assures the required mechanisms of a project that are an SVN 
repository, a template project wiki page, an issue tracker with tag support and a place to 
put releases (Origo, 2007). 
 
2.1.7. MS Product 

MS Product program which is one of the Protein Prospector Tools was 
developed in the University of California, San Francisco (UCFS). The Mass 
Spectrometry Facility is conducted at UCSF by Dr. Alma Burlingame, Professor of 
Chemistry and Pharmaceutical Chemistry (Burlingame). MS Product calculates 
theoretical ion masses from given peptides. The peptides undergo dissociation via post-
source decay or high- or low-energy collision-induced dissociation (Agilent Spectrum 
Mill MS Proteomics Workbench, 2010). 
Since MS Product presents the ion fragments with correct name from the given 
peptide, the accuracy of the ion naming algorithm was ensured by testing with MS 
Product. Peptide fragmentation model was used to build the name of the fragment ions. 
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2.1.8. Peptide Fragmentation Pattern 
 
 In order to name ions in tandem mass spectra, the peptide fragmentation model 
was used as indicated in Figure 2.2 The model enables us to exact mass differences 
between fragment ion types which are crucial for the calculation of the complements of 
the fragment ions. 
 
 
 
                                                                
 
 
Figure 2.2. Ion Complementarity by  Peptide Fragmentation Model. Fragmentation regions and formulas 
of  backbone fragment ions are shown (Source: Peptide fragmentation, 2010). 
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2.1. 9. Amino acid Mass 
 
The presence of isotopes ( C=12, C=13, C=14 etc.) at their natural abundances 
makes it essential to define whether an experimental mass value is an "average", or a 
"monoisotopic" value, While the monoisotopic mass is the mass of the first peak of the 
isotopic distribution, the average mass is the average masses of all of the peaks in the 
isotopic distribution.  
In order to clarify this situation, an example could be given. For instance, the 
monoisotoptic mass of a compound is 1155.6. For a given compound the monoisotopic 
mass is the mass of the isotopic peak whose elemental composition is composed of the 
most abundant isotopes of those elements. The monoisotopic mass can be calculated 
using the atomic masses of the isotopes. The average mass is the weighted average of 
the isotopic masses weighted by the isotopic abundances.  The average mass can be 
calculated using the atomic weights of the elements (Figure 2.3) (Ion source, 2005).   
 
 
 
Figure 2.3 Monoisotopic and Average Mass 
 (Source: Ion source, 2005). 
 
 
In the present study, both monoisotopic and average mass of the amino acid was 
considered for the tandem spectra dataset. In order to generate theoretical precursor ion 
mass from given peptide sequence of the dataset, the monoisotopic masses of the amino 
acids were used (Figure 2.4). In addition to the calculation of the theoretical precursor 
ion mass, the amino acid masses were used to generate theoretical ions masses. 
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Additionally, in the present study, the amino acid masses were used for determination 
amino acid sequence of the peptide. According to the value of the precursor ion mass, 
monoisotopic or average mass of amino acids were applied to find the peptide sequence.  


Table 2.1. Monoisotopic and Average mass of each one of the amino acids. 
 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                       
2.2 Method 
 
2.2.1. Default Values 
 
 In the present study, proper default values were established.  Default values 
were generated to reach the best settings for the Keller et al spectra data set. A Precursor 
mass tolerance, a fragment ion tolerance, ion types and windows settings were 
considered as default values to detect the best settings. 
1-letter 
code 
3-letter 
code 
Chemical 
formula 
Monoisotopic Average 
A Ala C3H5ON 7.103.711 710.788 
R Arg C6H12ON4 15.610.111 1.561.875 
N Asn C4H6O2N2 11.404.293 1.141.038 
D Asp C4H5O3N 11.502.694 1.150.886 
C Cys C3H5ONS 10.300.919 1.031.388 
E Glu C5H7O3N 12.904.259 1.291.155 
Q Gln C5H8O2N2 12.805.858 1.281.307 
G Gly C2H3ON 5.702.146 570.519 
H His C6H7ON3 13.705.891 1.371.411 
I Ile C6H11ON 11.308.406 1.131.594 
L Leu C6H11ON 11.308.406 1.131.594 
K Lys C6H12ON2 12.809.496 1.281.741 
M Met C5H9ONS 13.104.049 1.311.926 
F Phe C9H9ON 14.706.841 1.471.766 
P Pro C5H7ON 9.705.276 971.167 
S Ser C3H5O2N 8.703.203 870.782 
T Thr C4H7O2N 10.104.768 1.011.051 
W Trp C11H10ON2 18.607.931 1.862.132 
Y Tyr C9H9O2N 16.306.333 1.631.760 
V Val C5H9ON 9.906.841 991.326 
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For each setting, we calculated the statistics for all spectra. In order to determine 
the best settings, the result of statistics was compared to the current best result. In other 
words, we checked whether the results for a new setting were better than the ones that 
were currently the best. Therefore, when the new one was better, we accepted it as the 
best setting and overwrote to the current best one. In contrast, when the new one was 
worse, it was ignored and the current best one was saved.  
In the study, we detected the best settings to get statistics showing (found b- ion 
/theoretical-b-ion) score at maximum level, the minimum number of peaks in Named 
Spectrum and the minimum runtime. In accordance with this, we used those settings and 
similarly determined the best settings for b-ion Spectrum. In Chapter 3, the statistic is 
used to filter the named spectrum and b spectrum. 
 
 
 
 
 


                                         
 
                                       
              



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                                  CHAPTER 3 
 
                                   DENOVON 
 
3.1. Ion Complementarity 
 
As indicated in sections 2.1.8 and 1.1.1.3, if the charge is retained on the N-
terminus, peptide fragment ions are indicated by a, b, or c. On the contrary, if the charge 
is maintained on the C-terminus peptide fragment ions are stated by x, y or z. The 
subscript indicates the number of amino acid residues in the fragment. Superscripts are 
sometimes used to indicate neutral losses in addition to the backbone fragmentation, for 
the loss of ammonia and for loss of water. Although peptide backbone cleavage is the 
most useful for sequencing and peptide identification, other fragment ions may be 
observed in the tandem mass spectrum (Johnson, Martin, & Biemann, 1988) (Falick, 
Medzihradszky, Baldwin, & Gibson, 1993). Therefore, in the study not only b-type ions 
and y-type ions but also other ion types are considered to name ions by using ion 
complementarity (Table 3.1). 
 
 
Table 3.1. Ion Complementarity between fragment ions. (O = 15.999, C = 12.011, N = 14.007,  
                 H = 1.0079). 
 
         a         b         c         x            y        z  
      
a  
     +C+O  +C+O+ 
N+3H  
      
      
b  
 -C-O      +N+3H        
      
c  
-C-O- N-
3H  
-N-3H            
-O-C-       
x  
          -O-C+   2H  
N-H)  
      
y  
      +O+C-2N      -N-3H  
      
z  
      O+C+N+
H  
  +N+3H      
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We generate neutral loss ion types from backbone fragment ions and term them 
haphazardly. Therefore, eighteen different ion types are created (Table 3.2). 
 
Table 3.2. Neutral loss ion types. On the right column, neutral ion types are generated from backbone 
fragment ions . ( NH3= 17.0307, H2O= 18.0148). 
 
x -H2O =                   u 
y - H2O =                   v 
z - H2O =                   w 
x -NH3 =                   r 
y -NH3 =                   s 
z -NH3 =                   t 
a - H2O =                   d 
b - H2O =                   e 
c - H2O =                   f 
a -NH3 =                   g 
b -NH3 =                   h 
c -NH3 =                   i 
 
 
 
For each m/z (ion) value from experimental tandem mass spectrum (the data set 
is indicated in section 2.1.1), in the study we constitute eighteen different “guesses” 
namely: “a, b, c, x, y, z, u (x-H2O), v (y-H2O), w (z-H2O), r (x-NH3), s (y-NH3), t (z-
NH3), d (a-H2O), e (b-H2O), f (c-H2O), g (a-NH3), h (b-NH3), i (c-NH3)”. Equating 
between the eighteen different guesses are used to find corresponding names for ions. It 
is possible that the ion can correspond to different names. For this reason, the most 
abundant ion type and its proportion are found. Then, the most abundant ion type is 
accepted as a label per m/z window. In this way, the Named Spectrum is generated. 
By using the named ions (peaks) from the Named Spectrum, the named ions are 
translated into b-ion type by using fragment ion complementarity in order to create a b-
ion only spectrum. It is called b- ion Spectrum. We expect that the abundance of b-ions 
could increase cumulatively because there may be multiple named ions which support 
one b-ion.  
The main structure of the algorithm is illustrated in Figure 3.1 In order to 
explain it, three ions type which are a, b and c ions were created from MS-Product 
(2.1.7). As specified in Figure 3.1, named spectrum and b- ion spectrum are constituted. 
In b- ion spectrum, it is implied that a b- ion is found with high supports. Therefore, the 
algorithm, which is used, can account for missing b-ions in the experimental tandem 
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mass spectrum and assign b-ions. Hence, b-ion ladder can be determined in order to 
assign peptide sequence of experimental tandem mass spectrum. 
 
 
 
Figure 3.1. Ion Complementarity to generate Named and b-ion Spectrum. To reach b-ion ladder, firstly 
named spectrum is generated from MS/MS spectrum. As shown in the named s., some peaks 
are more interesting because they carry same ion type assignments. Then, these interesting 
peaks are translated into b-ion. Since they correspond same b-ion peak, the abundance of b-
ion is increased. 
 
 
Finding the full b-ion ladder with high supports and reducing the number of 
potential noise peaks as much as possible is a challenging task in the present study 
because of complexity of the experimental tandem mass spectrum and the named 
spectrum. Therefore, we need to add some steps to the named spectrum in order to 
decrease complexity and increase the supports of interesting peaks. Running sum and 
peak centering are applied to increase the supports of the important named peaks and 
lift them out from the potential noise. Then, filtering provides us to have the important 
named peaks with high supports and as few potential noise peaks as possible. After that, 
the named peaks are translated into b-ion peak by using fragment ion complementarity 
in order to generate b- ion spectrum. Because of the same reason with the named 
spectrum, b- ion spectrum requires peak centering and filtering. Then, the obtained b-
ion peaks are traversed to the matrix application of Spectrum Graph. Ultimately, 
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dynamic programming is used to find best peptide sequence from all possible amino 
acid sequence. The DENOVON algorithm is illustrated in Figure 3.2. 
Naming Ions, Running Sum, Peak Centering, Filtering, Translation, Spectrum 
Graph and Dynamic Programming, which are steps of the DENOVON algorithm, are 
explained, in this section. 
 
 
                                      
Figure 3.2. DENOVON algorithm. The steps of the DENOVON algorithm are shown to reach peptide 
sequence. 
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3.2. Naming Ions 
 
The tandem mass spectra data set was measured by a LCQ MS/MS as indicated 
in section 2.1.1  As specified in section 2.2.1, we determine the best ion type set among 
eighteen different ion types for the data set. The best ion type set is “b-y-h (b-
ammonia)-c-i (c-ammonia)-u (x-water)-v (y-water)” (As indicated in Table 3.2 and 
Table 3.1). Therefore, the best ion type set is used to generate the named spectrum from 
the experimental spectrum. In other words, as explained in section 3.1 and indicated in 
section 2.1.8, we assume one of the best ion types for each ion of the tandem mass 
spectrum then translate this ion type to the other best ion types by using fragment ion 
complementarity. In conclusion, the named spectrum is created for each spectrum. 
In Figure 3.3, an example of a named spectrum is shown. In order to represent 
how running sum and peak centering are performed, the named spectrum was 
simplified. Therefore, the named spectrum which is indicated in Figure 3.3 is not real. 
In other words, this named spectrum was created manually because it is more 
comprehensible. 
It is required to state that the actual figures which belong to the named spectrum 
and b spectrum are indicated in the results and discussion chapter. 
 
                                                 
 
 
 
Figure 3.3. An Example of the Named Spectrum. 
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3.3. Running Sum 
 
Firstly, in the present study, running sum is applied to the Named Spectrum in 
order to increase the abundance of interesting peaks and lift them out from the 
background of potential noise peaks. 
Interesting peak means that it carries the same ion name type more than once. 
Therefore, the ion name assignment in such a peak is more valuable, because the same 
ion type provides support to name the peak. Moreover, these interesting peaks need to 
be considered.   
Since we increase the abundance of ions in the experimental spectrum, the peaks 
in the named spectrum are adjacent to each other. Hence, we look for adjacent peaks to 
the interesting peaks whether they include the same ion type with the interesting peak or 
not. 
Figures 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, 3.10 and 3.11 show how running sum is 
performed in order to sharpen the interesting peaks. In a sliding window of size, the 
middle peak is considered if the most abundant name whether it is bigger than a 
threshold (Figure 3.6 and 3.10). If so, its adjacent peaks are checked whether they have 
same ion name assignment with the middle peak or not. After that, we add the value of 
the adjacent peak to the middle one if they have the same assignment (Figures 3.6, 3.7, 
3.10 and 3.11). In this way, the support of interesting peaks is increased and the count 
of peaks in the named spectrum is decreased. Therefore, the complexity of the named 
spectrum is decreased (Figure 3.12). 
 
 
 
 
Figure 3.4. Step 1 of the Running Sum. Sliding window size is 0,7 and most abundant ion threshold is 2. 
Middle peak in the window size does not provide the threshold requirement. 
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Figure 3.5. Step 2 of the Running Sum. Middle peak in the window size does not provide the threshold 
requirement. 
 
 
 
 
 
Figure 3.6. Step 3 of the Running Sum. Sliding. Middle peak in the window size provides the threshold 
requirement. Also, its adjacent peaks have same ion assignment which is ‘u’. 
 
 
 
 
 
Figure 3.7. Step 4 of the Running Sum. In the former figure (Figure 3.6), a count of the abundance of 
interesting peak is two , after running sum it is increased four.  In this sliding window, middle 
peak in the window size does not provide the threshold requirement. 
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Figure 3.8. Step 5 of the Running Sum. 
 
 
 
 
 
Figure 3.9. Step 6 of the Running Sum. 
 
 
 
 
Figure 3.10. Step 7 of the Running Sum. Middle peak in the window size provides the threshold 
requirement. Also, its adjacent peaks have same ion assignment which is ‘y’. 
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Figure 3.11. Step 8 of the Running Sum. In the former figure (Figure 3.10), a count of the abundance of 
interesting peak is two , after running sum it is increased four.  In this sliding window, middle 
peak in the window size does not provide the threshold requirement. The running sum 
algorithm continues to the end of the named spectrum. 
 
 
 
 
 
 
Figure 3.12. An Example of the Named Spectrum after applying the Running Sum. The complexity of 
named spectrum is decreased and the support of interesting peaks are increased. 
 
  
 
Although, according to the DENOVON algorithm, the next step is filtering, peak 
centering is explained in order to use the same figures for clarification.  
  
3.4. Peak Centering 
 
After applying running sum, the count of peaks in the named spectrum is 
decreased. Moreover, as indicated in the Figure 3.12, the interesting peaks include only 
the same ion type. 
The next step in the study is the peak centering to sharpen the interesting peaks 
and to remove the potential noise peaks. 
In a sliding window, the adjacent peaks are checked whether they carry the same 
ion type or not. If the ion type is the same, the middle peak is calculated as a sum of m/z 
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values. Then, the values of the adjacent peaks are added to the middle peak (Figures 
3.12, 3.13, 3.15, 3.16 and 3.17). 
As indicated in Figure 3.18, an implementation of the running sum and peak 
centering the named spectrum provides us to enhance the value of the interesting peaks. 
Therefore, the interesting peaks become more distinctive than the other potential noise 
peaks. 
 
 
 
 
Figure 3.13. Step 1 of the Peak Centering. A sliding window size is 1.5 Da. In the window, the adjacent 
peaks carry  same ion type. A middle peak is calculated and shown in Figure 3.14. 
 
 
 
 
 
Figure 3.14. Step 2 of the Peak Centering. In the window, the adjacent peaks do not carry same ion type. 
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Figure 3.15. Step 3 of the Peak Centering. In the window, two of adjacent peaks carry same ion type. A 
middle peak is calculated and the values of the adjacent peaks are summed as shown in 
Figure 3.16. 
 
 
 
 
 
 
Figure 3.16. Step 4 of the Peak Centering. In the window, two of the adjacent peaks carry same ion type. 
A middle peak is calculated and the values of the adjacent peaks are summed as shown in 
Figure 3.17.  
 
 
 
 
 
Figure 3.17. Step 5 of the Peak Centering. The most abundant ion threshold is three. Therefore, the peak 
which is smaller than the threshold is eliminated. 
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 Figure 3.18. An Example of the Named Spectrum after applying the Running Sum and Peak Centering. 
The abundance of interesting peaks is increased and potential noise peaks are reduced. 
 
 
 
As explained before in section 3.2 Naming Ions, the peak centering and the 
running sum were explained using the named spectrum. In addition, the named 
spectrum which is used in the figures was generated manually. Therefore, the actual 
versions of the named spectrum are shown in the Results and Discussion Chapter. In 
other words, the named spectrum, after applying the running sum the named spectrum 
and the peak centering the named spectrum are shown in the figures in the Results and 
Discussion Chapter.  
In the present study, the next step is applied the named spectrum is filtering. 
 
3.5. Filtering 
 
 Filtering is used in order to remove unexplained data from the spectrum in 
various de novo sequencing algorithms, for example, PEAKS which is indicated in 
section 1.1.3.1. 
The named spectrum is more complicated than the figures which are shown in 
this chapter. Therefore, in addition to the running sum and the peak centering, filtering 
is required to obtain interesting peaks and separate them from potential noise peaks. We 
apply a sophisticated filtering approach to the named spectrum. To perform this, the 
named spectrum is divided into five windows. For each window, the specific threshold 
is determined statistically. In order to calculate the specific thresholds, all the data set 
was considered at the same time because the thresholds which belong to five windows 
are then used to cut to the named peaks. If support of the named peak in the window is 
bigger than the threshold, the named peak is taken because of its importance. If not, the 
named peak is removed. 
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In the present study, the next step of the algorithm is the translation. It translates 
the named peaks into the b-ion Spectrum. 
 
3.6. Translation, Peak Centering and Filtering 
 
As shown in the Figure 3.2 and as indicated in 3.1, the translation is a latter step 
in the algorithm. The named peaks in the named spectrum which are bigger than a 
threshold are translated into the b- ion peaks by using fragment ion complementarity in 
order to generate a spectrum which includes only b-ions.  
The b-ion spectrum should include a full b-ion ladder and as few as possible 
potential noise peaks. Since it is necessary to decrease the count of the potential noise 
peaks in the b- ion spectrum, peak centering and filtering are applied to the b- ion 
spectrum. 
As explained in the section 3.4, the same logic can be used for the b- ion 
spectrum because the aim of application of the peak centering is the same for both the 
named spectrum and the b-ion spectrum. Unlike the named spectrum, the b-ion 
spectrum includes only b-ion peaks. Therefore, in order to find the middle peak, the 
support of the b-ion is considered. Then, the support of the important peak is increased. 
Afterwards, the filtering approach is conducted on the b-ion spectrum in order to 
obtain full b-ion ladder and to reduce the potential noise peaks as much as possible. In 
the section 3.5, the filtering is explained elaborately. Also, the reason for 
implementation of the filtering is the same for both the named spectrum and the b-ion 
spectrum. 
 
3.7. Spectrum Graph and Dynamic Programming 
 
An ideal tandem mass spectrum does not have unexplained peaks and contains 
only b-ions and y-ions, and every ion peak has similar abundance. Eventually, the 
filtered b-ion spectrum almost reaches to the ideal tandem mass spectrum because it 
includes b-ion ladder and potential noise b-ion peaks as few as possible. Therefore, they 
can be used to find the peptide sequence. 
As explained in section 1.1.2.2, there are two major steps in order to find the 
peptide sequence. The first step is to generate a pool of candidate sequences. The 
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second step is to design a scoring function to select the best candidate from the pool. To 
do these, most de novo algorithms create a spectrum graph and then apply a dynamic 
programming algorithm to find paths in the graph that represent peptide candidates 
(Alves & Yu, 2005), (Chen, Kao, Tepel, Rush, & Church, 2001), (Dancik, Addona, 
Clauser, Vath, & Pevzner, 1999), (Lu & Chen, 2003) and (Ma, Doherty-Kirby, & 
Lajoie, 2003). 
In the present study, the b-ions and the precursor mass of the tandem mass 
spectrum are traversed to the matrix application of spectrum graph. Each peak in the b- 
ion spectrum serves as vertex. A directed edge connects two vertices in the spectrum 
graph if the difference between the vertices’ masses is the mass of a single amino acid. 
Precision (closeness of fit for amino acid) and naming confidence of vertices make up 
the weights for the edges and vertices. This, then, enables us to determine the highest 
scoring path and offer it as the amino acid sequence that gave rise to the MS/MS 
spectrum. 
 
 
 
Figure 3.19. Example peaks of b-ion Spectrum.  shows the absolute error. W= monoisotopic mass 
186.07931, W=average mass 186.2132. 
 
 
 
 In Figure 3.19, two example b-ion peaks of a spectrum are shown to explain 
how the scoring function is calculated. According to the figure, the m/z value of the first 
peak is 274,5 (V1) and its naming support is  160,3. Similarly, 460,8 (V2)  is the m/z 
value of the second peak and 141,2 is its naming support. The first parameter for 
calculating scoring function is an absolute error. As explained above, the mass 
difference between two vertices is 186,3. Although the mass of W (Trp) is not equal to 
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the difference exactly, the edge (E) connects two vertices because an absolute error is 
considered as 0,7 Da. The second parameter is the naming confidence of the vertices. 
To do that, the average of the naming confidences is calculated. Therefore, these 
parameters create a weight to the edge (Figure 3.20).  The scoring provides us to 
determine the highest scoring path among all possible peptide sequences and offer it as 
the amino acid sequence of the MS/MS spectrum. 
 
3.8. Class Diagram 
  
A class diagram is a type of static structure diagram that describes the structure 
of a system by showing the system's classes and the relationships between the classes. 
 Figure 3.20 shows the most important classes which are generated for the 
present study and the relationships between these classes. 
 
 
                                       
   Figure 3.20. Class Diagram. 
                                        
 41 
CHAPTER 4 

                          RESULTS AND DISCUSSION 
 
In Chapter 3, the DENOVON algorithm is explained in order to obtain b-ion 
ladder and as few noise peaks as possible from an experimental tandem mass spectrum. 
This simplifies the complexity of experimental spectrum and b-ions which are important 
for peptide identification can be found.  
 
4.1. Named Spectrum 
 
The Figure 4.1 is from the published data set (Keller et al., 2002) in section 2.1.1 
As shown in the Figure 4.1, the number of peaks is 221. 
                   
 
 Figure 4.1. Experimental Tandem Mass Spectrum. It belongs to the data set as indicated in section 2.1.1 
is an experimental tandem mass spectrum. Before processing the algorithm, peak count of the 
VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum is 221. 
 
 
  
As can be seen in Figure 4.2, by using ion complementarity the named spectrum 
was generated from the experimental tandem mass spectrum as explained in section 3.2 
Since the number of potential noise peaks seems high and interesting peaks needed to 
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be increased in abundance, running sum, filtering and peak centering were applied to 
the named spectrum. 
 
 
Figure 4.2. Named Spectrum. A proportion of the most abundant ion type is referred as y-axis. The 
proportion shows naming confidence for each peak. After naming ions, peak count increases 
from 221 to 4635 for the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta 
spectrum. 
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4.2. Running Sum the Named Spectrum 
 
After applying running sum (section 3.3) to the named spectrum (Figure 4.2), 
the support of interesting peaks is increased and the number of potential noise peaks is 
decreased as illustrated in Figure 4.3 To demonstrate the change of the proportion of 
most abundant ion type of interesting peaks is shown as circle in the Figures 4.2, 4.3, 
4.4 and 4.5. In addition, in order to point out the change in number of peaks, the Peak 
Count is also illustrated in all figures in this chapter. 
             
 
 Figure 4.3. After running sum, appearance of the Named Spectrum. Peak count reduces from 4635 
to1423 for the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. Also, 
the proportion of the most abundant ion type increases from 5 to 14. 
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4.3. Filtering the Named Spectrum 
 
As explained in section 3.5, according to specific thresholds for each window, 
the number of peaks was reduced as shown in the Figure 4.4. Since filtering provides a 
decrease the count of possible noise, a change in proportion of the most abundant ion 
type does not occur. 
 
 
Figure 4.4. After filtering, appearance of the Named Spectrum. Peak count decreases from 1423 to      
1036 for the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. 
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4.4. Peak Centering the Named Spectrum 
 
As explained in the section 3.4, the support of interesting named peaks is 
increased in order to lift them out from the potential noise peaks (Figure 4.5). 
 
 
 Figure 4.5. After peak centering, appearance of the Named Spectrum. Peak count decreases from 1036 to 
642 for the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. In 
addition, naming confidence increases from 14 to 90. 
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4.5. Filtering the Named Spectrum 
 
The next step in the present study is also filtering as indicated in Figure 3.2. As 
shown in Figure 4.6, the complexity of the named spectrum was reduced.  
 
 
Figure 4.6. After filtering, appearance of the Named Spectrum. Peak count decreases from 642 to 456 for 
the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. 
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4.6. b-ion Spectrum 
  
By exploiting fragment ion complementarity, the named peaks are, then, 
translated into b-ion type in order to generate the spectrum which includes only b-ions 
as explained in section 3.1 and section 3.6. 
Cumulative b-ion abundance is given on the y-axis in b-ion Spectrum. We 
expected that the abundance of b-ions could increase and peak count could decrease 
because there may be multiple named ions which support one b-ion. Therefore, as 
shown in Figure 4.7, peak count is less than in Figure 4.6 and the abundance of y-axis is 
higher than in Figure 4.6 Both results support our expectation. 
 
 
Figure 4.7. b-ion Spectrum. The b-ion abundance increases from 90 to 120. In addition, peak count 
reduces from 456 to 303 for the VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta 
spectrum. 
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4.7. Filtering the b-ion Spectrum 
 
      Figure 4.8 shows elimination of the potential noise peaks according to determined 
threshold for each window. 
             
 
Figure 4.8. After filtering, appearance of the b-ion Spectrum. Since peak count decreases from 303 to 
189, the complexity of VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum 
reduces. 
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4.8. Peak Centering the b-ion Spectrum 
 
As illustrated in the Figure 4.9, the support of interesting b-ions is increased and 
the number of potential noise peaks is reduced. 
             
 
Figure 4.9. After peak centering, appearance of the b-ion Spectrum. The b-ion abundance increases from 
120 to 250. In addition, peak count reduces from 189 to 70 for the 
VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. 
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4.9. Filtering the b-ion Spectrum  
 
As shown in Figure 3.2, the next step is filtering the b-ion spectrum. The b-ion 
peaks which are smaller than determined threshold were removed from the b-ion 
Spectrum (Figure 4.10). 
 We achieved to gain a b-ion ladder which enables us to assign a peptide 
sequence to an experimental tandem mass spectrum. In addition, in contrast to an 
experimental tandem mass spectrum, peak count is reduced and b-ions are enriched as 
shown in Figure 4.10 Therefore, the unexplained peaks from experimental tandem mass 
spectrum are decreased.  
 
 
Figure 4.10. After filtering, appearance of the b-ion Spectrum. Peak count reduces from 189 to 70 for the 
VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. In addition, b-ion 
ladder which provides to find peptide sequence is shown in the figure. PM is a precursor 
mass of the spectrum. 
 
 
 
While we managed to gain full b- ion ladder for 10 spectra which were assigned 
with short peptide sequence, we could not find full b- ion ladder for 740 spectra which 
was designated with long peptide sequence. Since LCQ tandem mass spectra have a low 
resolution for low m/z range and for high m/z range, obtaining the first b-ion and the 
last b-ion is a challenging task. As shown in Figure 4.10, the last b-ion which is b10 for 
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VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta tandem mass spectrum is 
not found. However, nonexistence of the last b-ion does not cause a problem to identify 
peptide because it would be just a precursor mass as indicated in Figure 4.10. The 
results which belong to VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta are 
shown in Table 4.1. and Table 4.2. 
 
 
Table 4.1. After Processing DENOVON. After processing the algorithm, peak count is reduced 5 times in 
VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. In addition, while 
found b-ions/ theoretical b-ions ratio is 0,7 in the experimental tandem mass spectrum, after 
processing the algorithm the ratio is increased to 0,9. It means that some missing b-ions in the 
experimental tandem mass spectrum are found. 
 
 Peak Count  Found b-ions/Theoretical b-ions  
Before Processing         221              0,7  
After Processing          43              0,9  
              
 
 
Table 4.2. Found and Expected Sequence. The relative distance is 6 between expected and found peptide 
sequence in VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta spectrum. 
 
        Expected           Found      Relative Distance  
Sequence  VGDANPALQK VGDAPGALQY     6  
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Table 4.3. Evaluation quality of LCQ Experimental Tandem Mass Spectra. The spectra belong to 
published data set (Source: Keller et al, 2002). According to precursor mass tolerance, 1405 
spectra were eliminated from 3000 spectra. Then, the high quality spectra were selected from 
1872 appropriate spectra in order to evaluate the DENOVON. 
 
 
 
 
 
Table 4.4. Results of high quality LCQ Experimental Tandem Mass Spectra. The spectra belong to 
published data set (Source: Keller et al, 2002). After processing the algorithm, the peak count 
of 754 spectra is reduced 2.5 times. In addition, before and after processing of DENOVON on 
754 spectra, found b-ions/ theoretical b-ions ratio is similar. All mean that while processing 
of the spectra we do not lose b-ion ladder which is important for peptide identification. In 
addition, the complexity of the spectra is reduced. 
 
Appropriate  and 
High Quality Spectra  
 
Peak Count Found b-
ions/Theoretical 
b-ions  
Before Processing  210,2  0,70  
After Processing 81,5 0,69  
 
 
 
As indicated in Table 4.3, DENOVON algorithm was evaluated on 754 spectra 
which belong to the published data set. As shown in Table 4.4, 0,69 is the ratio of found 
b-ions/theoretical b-ions for the 754 spectra. The ratio indicates that we reached b-ion 
ladder after processing our algorithm. In addition, the peak count of the spectra was 
reduced significantly. Therefore, then, we can find amino acid sequence of peptide of 
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these spectra. Moreover, the DENOVON algorithm established missing b- ions for 21 
spectra of the 754 spectra. Hence, not only correct name assignment to ion and reducing 
the complexity of experimental tandem mass spectrum was managed, but also some 
missing b- ions were found for some spectra. It can be indicated for the spectrum 
“VGDANPALQK_sergei_digest_A_full_01.0485.0487.2.dta” because the ratio of 
found b-ions/theoretical b-ions is increased after processing the algorithm as shown in 
Table 4.1. 
In order to evaluate our DENOVON algorithm, it is necessary to compare to 
another algorithm on the same data set. Therefore, we compared our algorithm to 
PepNovo algorithm (in section 1.1.3.2) which is one of the popular de novo sequencing 
algorithm. We used the same 754 experimental tandem mass spectra for evaluation of 
two different algorithms. However, PepNovo found peptide sequences for only 72 
spectra of 754 spectra. Hence, by using PepNovo algorithm, we could not reach any 
result for 682 spectra of the 754 spectra. Differently, DENOVON algorithm managed to 
obtain peptide sequence for all of the 754 spectra. In order to compare our algorithm to 
PepNovo, we needed to divide the spectra in two as 72 spectra and the rest of the 
spectra due to limitation of PepNovo. In addition, since PepNovo can find peptide 
sequence for only limited number of the spectra, for the rest of the spectra we used b-
ion spectra which are generated by DENOVON algorithm form experimental spectra. In 
Figure 4.11, results of PepNovo algorithm are shown for 72 spectra of the experimental 
spectra, 72 spectra of b-ion spectra, the rest of the b-ion spectra. Relative distance 
indicates accuracy of the algorithm for the spectra. If relative distance is high for the 
spectra, it means the accuracy of peptide assignments is low. The correctness of 
DENOVON algorithm for the experimental spectra is shown in Figure 4.12. 
 









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
 
Figure 4.11. Relative Distance of the PepNovo for LCQ MS/MS Spectra which are published data set 
(Source: Keller et al, 2002).  shows average relative distance between expected and 
found peptide sequences. Exp.S. (72) has average relative distance as 3,8,  minimum relative 
distance as 0 and maximum relative distance as 11. b-ion S. (72) has average relative 
distance as 7, minimum relative distance as 0 and maximum relative distance as 13. b-ion S. 
(72-754) has average relative distance as 7, minimum relative distance as 0 and maximum 
relative distance as 13. 
 
 
 
 
 
 









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
 
Figure 4.12. Relative Distance of the DENOVON for LCQ MS/MS Spectra which are published data set 
(Source: Keller et al, 2002).  shows average relative distance between expected and found 
peptide sequences. Exp.S. (72) has average relative distance as 8, minimum relative distance 
as 3 and  maximum relative distance as 12. Exp S. (72-754) has average relative distance as 
7,9, minimum relative distance as 1 and maximum relative distance as 13. 
 
 
 
 
As indicated in Figure 4.11, although the accuracy of the PepNovo seems good 
for the 72 spectra of the experimental tandem mass spectra, it cannot generate any 
peptide assignment to the rest of the experimental tandem mass spectra. Therefore, we 
managed to evaluate the accuracy of PepNovo by using b-ion spectra which are 
generated by the DENOVON. In Figure 4.12., DENOVON algorithm is evaluated on 
the experimental tandem mass spectra. Both 72 spectra and the rest of the spectra have 
similar correctness to peptide assignment. Also, they have similar relative distance with 
b-ion spectra in Figure 4.11 The results show that the DENOVON can find peptide 
sequence to experimental tandem mass spectra. In addition, b-ion spectra can be used to 
reach peptide assignment for the PepNovo algorithm. In future, the accuracy of the 
DENOVON will be increased to reach full sequence of peptides. 
 
 56 
CHAPTER 5 

CONCLUSION 
 
Mass spectrometry based proteomics is a remarkably powerful approach in to 
identify proteins in complex biological samples. Since correct peptide assignment is a 
key step for protein identification, huge number tandem mass spectra are frequently 
generated in proteomics experiments and they require challenging data analysis. Despite 
recent improvements in identification methods, a significant number of spectra remain 
unidentified due to post translational modifications, mutations and incompleteness of 
protein databases. These spectra may represent meaningful biological information and 
are potentially identifiable with de novo sequencing because it can assign amino acid 
sequence of peptide to tandem mass spectrum without the need of a protein database. 
Unknown fragment ion types, unknown charges, incomplete fragmentation, 
unexplained data, isotopic ions, and machine errors are limiting algorithms while 
analyzing. Therefore, up to this point, different de novo sequencing algorithms were 
developed to manage some difficulties while identifying peptides. 
The aim of this study was to enhance the accuracy of de novo sequencing 
algorithms. Naming of fragment ions is one common step in all de novo sequencing 
algorithms because it is essential to know which peak represents which ion type in order 
to traverse a spectrum graph to find an amino acid sequence of peptide. Different 
approaches have achieved to name b-type ions and y-type ions.  
We have presented a new approach which provides the naming of not only b- 
type ions and y-type ions but also other arbitrary ion types. By exploiting fragment ion 
complementarity, the detection of full b-ion ladders for tandem mass spectra data set 
was achieved in some cases. In addition, unexplained data in the data set was reduced 
substantially. Moreover, missing fragments in some of the data set have been 
determined by using other named ion types. In order to evaluate the accuracy of 
DENOVON algorithm, our algorithm was compared to PepNovo algorithm. While 
PepNovo can find peptide assignments to 72 experimental spectra of the data set, the 
DENOVON algorithm can assign peptide sequences to 754 experimental spectra of the 
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data set. In order to reach full sequence of peptides, the correctness of DENOVON will 
be enhanced in future. 
It is possible that the development of this novel method, and the enhancement of 
the remaining approach, to de novo sequencing of tandem mass spectra will have great 
influence on mass spectrometry and proteomics since owing to properly named 
fragment ions more difficult task like the de novo sequencing of tandem mass spectra 
with post translational modifications can be enabled.This may impact clinical research 
by enabling the direct analysis of proteins without prior knowledge of their origin.It is 
anticipated that DENOVON algorithm might popularize in proteomics laboratories 
because of overcoming the limitation of database search. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

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